Browsing by Author Sala, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 28  next >
Issue DateTitleAuthor(s)
16-Feb-2020ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinomaAndersson, MK; Mangiapane, G; Nevado, PT; Tsakaneli, A; Carlsson, T; Corda, G; Nieddu, V; Abrahamian, C; Chayka, O; Rai, L; Wick, M; Kedaigle, A; Stenman, G; Sala, A
2012A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastomaSottile, F; Gnemmi, I; Cantilena, S; D'Acunto, WC; Sala, A
2009Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomasChakya, O; Corvetta, D; Dews, M; Caccamo, AE; Piotrowska, I; Santilli, G; Gibson, S; Sebire, NJ; Himoudi, N; Hogarty, MD; Anderson, J; Bettuzzi, S; Thomas-Tikhonenko, A; Sala, A
2016Cutaneous cylindroma: it's all about MYBCorda, G; Sala, A
13-May-2015Editorial: Targeting MYCN in pediatric cancersSala, A
2019Engineered human mesenchymal stem cells for neuroblastoma therapeuticsKarteris, E; Nieddu, V; Piredda, R; Bexel, D; Barton, J; Anderson, J; Sebire, N; Kolluri, K; Janes, SM; Sala, A
3-Sep-2022Engineered model of t(7;12)(q36;p13) AML recapitulates patient-specific features and gene expression profilesRagusa, D; Cicirò, Y; Federico, C; Saccone, S; Bruno, F; Saeedi, R; Sisu, C; Pina, C; Sala, A; Tosi, S
23-Feb-2024Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapiesCicirò, Y; Ragusa, D; Sala, A
2015Frizzled receptor 6 and risk of metastatic recurrence in early triple negative breast cancerCorda, Gabriele
2011Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomasCantilena, S; Pastorino, F; Pezzolo, A; Chayka, O; Pistoia, V; Ponzoni, M; Sala, A
9-Nov-2016Functional and prognostic significance of the genomic amplification of frizzled receptor 6 ( FZD6 ) in breast cancerCorda, G; Sala, G; Lattanzio, R; Iezzi, M; Sallese, M; Fragassi, G; Lamolinara, A; Mirza, H; Barcaroli, D; Ermler, S; Silva, E; Yasaei, H; Newbold, RF; Vagnarelli, P; Mottolese, M; Natali, PG; Perracchio, L; Quist, J; Grigoriadis, A; Marra, P; Tutt, AN; Piantelli, M; Iacobelli, S; De Laurenzi, V; Sala, A
2017Generation of a novel Antibody-Drug Conjugate targeting endosialin: potent and durable antitumor response in sarcomaSala, A
2015Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cellsChayka, O; D'Acunto, CW; Middleton, O; Arab, M; Sala, A
30-Jun-2021Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved SurvivalTagalakis, AD; Jayarajan, V; Maeshima, R; Ho, KH; Syed, F; Wu, L-P; Aldossary, AM; Munye, MM; Mistry, T; Ogunbiyi, OK; Sala, A; Standing, JF; Moghimi, SM; Stoker, AW; Hart, SL
2020Investigating the role of exosomes in MYCN tumourigenesis and neuroblastoma-
2023Investigating the role of the MYB-BUB1 axis in adenoid cystic carcinomaCicirò, Ylenia
19-Dec-2023The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinomaCicirò, Y; Ragusa, D; Nevado, PT; Lattanzio, R; Sala, G; Des Rochers, T; Millard, M; Andersson, M; Stenman, G; Sala, A
2021Modelling the t(7;12) leukaemia using gene editing technologyRagusa, Denise
26-Feb-2021MYB oncoproteins: emerging players and potential therapeutic targets in human cancerCicirò, Y; Sala, A
1-Dec-2021MYC regulates metabolism through vesicular transfer of glycolytic kinasesTsakaneli, A; Carregari, VC; Morini, M; Eva, A; Cangemi, G; Chayka, O; Makarov, E; Bibbò, S; Capone, E; Sala, G; De Laurenzi, V; Poon, E; Chesler, L; Pieroni, L; Larsen, MR; Palmisano, G; Sala, A